Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Larsson

Showing results (21-30 of 409) with videos related to

Pageof 41
Sort By:
Acta Diabetologica|December 1, 1996
Plasma neuropeptide Y in impaired glucose toleranceB Ahrén, H Larsson
Arzneimittel-Forschung|October 1, 1974
Percutaneous absorption of benzydamine in guinea pig and manK Andersson, H Larsson
Acta Physiologica Scandinavica|August 1, 1974
Effects of barbiturates on synthesis and rapid axonal transport of protein in vitro in the sciatic system of the frogA Edström, H Larsson
Comparative Biochemistry and Physiology. B, Comparative Biochemistry|January 1, 1979
Differences in microtubule stability to colchicine in extracts of guinea pig, rat and rabbit brainM Wallin, H Larsson
Clinical Physiology (Oxford, England)|January 1, 1985
Pulmonary blood flow determination with selective rebreathing of CO2D Linnarsson, H Larsson
Diabetes Care|June 2, 2000
Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose toleranceH Larsson, B Ahrén
Diabetologia|November 24, 2001
Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrationsB Ahrén, H Larsson
The Journal of Clinical Endocrinology and Metabolism|December 1, 1996
Short-term dexamethasone treatment increases plasma leptin independently of changes in insulin sensitivity in healthy womenH Larsson, B Ahrén
European Journal of Endocrinology|March 1, 1996
Peptide YY does not inhibit glucose-stimulated insulin secretion in humansB Ahren, H Larsson
Metabolism: Clinical and Experimental|April 1, 1996
Islet dysfunction in obese women with impaired glucose toleranceH Larsson, B Ahrén
Pageof 41

Showing results (21-30 of 409) with videos related to

Sort By:
Pageof 41
Acta Diabetologica|December 1, 1996
Plasma neuropeptide Y in impaired glucose toleranceB Ahrén, H Larsson
Arzneimittel-Forschung|October 1, 1974
Percutaneous absorption of benzydamine in guinea pig and manK Andersson, H Larsson
Acta Physiologica Scandinavica|August 1, 1974
Effects of barbiturates on synthesis and rapid axonal transport of protein in vitro in the sciatic system of the frogA Edström, H Larsson
Comparative Biochemistry and Physiology. B, Comparative Biochemistry|January 1, 1979
Differences in microtubule stability to colchicine in extracts of guinea pig, rat and rabbit brainM Wallin, H Larsson
Clinical Physiology (Oxford, England)|January 1, 1985
Pulmonary blood flow determination with selective rebreathing of CO2D Linnarsson, H Larsson
Diabetes Care|June 2, 2000
Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose toleranceH Larsson, B Ahrén
Diabetologia|November 24, 2001
Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrationsB Ahrén, H Larsson
The Journal of Clinical Endocrinology and Metabolism|December 1, 1996
Short-term dexamethasone treatment increases plasma leptin independently of changes in insulin sensitivity in healthy womenH Larsson, B Ahrén
European Journal of Endocrinology|March 1, 1996
Peptide YY does not inhibit glucose-stimulated insulin secretion in humansB Ahren, H Larsson
Metabolism: Clinical and Experimental|April 1, 1996
Islet dysfunction in obese women with impaired glucose toleranceH Larsson, B Ahrén
Pageof 41